TY - JOUR
T1 - Primary solid neoplasms of the greater omentum
AU - Schwartz, R. W.
AU - Reames, M.
AU - McGrath, P. C.
AU - Letton, R. W.
AU - Appleby, G.
AU - Kenady, D. E.
PY - 1991
Y1 - 1991
N2 - Primary solid tumors of the greater omentum are rare, with only 42 reported cases. Malignant hemangiopericytomas constitute only three of these cases. The 40-year-old patient described in this report had abdominal pain, a palpable abdominal mass, early satiety, and weight loss. At laparotomy a large omental hemangiopericytoma was excised, and no other evidence of disease was grossly evident. Eighteen months after initial laparotomy, the patient had widespread progression of the tumor and, despite chemotherapy, died 2 months later. A review of reported cases shows that abdominal discomfort (56%) and mass (35%) are the most common clinical characteristics of a primary omental tumor. Weight loss, ascites, and peritoneal implants usually indicate malignancy. Rare long-term follow-up prevents definitive conclusions regarding therapy and prognosis. At present, surgical excision alone appears to be the treatment of choice, with no demonstrable benefit from either chemotherapy or radiation.
AB - Primary solid tumors of the greater omentum are rare, with only 42 reported cases. Malignant hemangiopericytomas constitute only three of these cases. The 40-year-old patient described in this report had abdominal pain, a palpable abdominal mass, early satiety, and weight loss. At laparotomy a large omental hemangiopericytoma was excised, and no other evidence of disease was grossly evident. Eighteen months after initial laparotomy, the patient had widespread progression of the tumor and, despite chemotherapy, died 2 months later. A review of reported cases shows that abdominal discomfort (56%) and mass (35%) are the most common clinical characteristics of a primary omental tumor. Weight loss, ascites, and peritoneal implants usually indicate malignancy. Rare long-term follow-up prevents definitive conclusions regarding therapy and prognosis. At present, surgical excision alone appears to be the treatment of choice, with no demonstrable benefit from either chemotherapy or radiation.
UR - http://www.scopus.com/inward/record.url?scp=0025856020&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025856020&partnerID=8YFLogxK
M3 - Article
C2 - 2008659
AN - SCOPUS:0025856020
SN - 0039-6060
VL - 109
SP - 543
EP - 549
JO - Surgery
JF - Surgery
IS - 4
ER -